Clinical and laboratory assessment of the bleeding pediatric patient

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 7, 2011, Pages 756-762

  Revel Vilk, Shoshana ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

assessment; Bleeding disorder; bleeding questionnaires; children; laboratory screening

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; BLEEDING DISORDER; BLEEDING TENDENCY; BLOOD ANALYSIS; BLOOD SAMPLING; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; DISEASE PREDISPOSITION; DISEASE SEVERITY; FAMILY HISTORY; HEMOSTASIS; HUMAN; LABORATORY DIAGNOSIS; MEDICAL HISTORY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SCREENING TEST; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE; WISKOTT ALDRICH SYNDROME;

BLOOD CELL COUNT; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; CHILD; COAGULATION PROTEIN DISORDERS; FAMILY HEALTH; HEMATOLOGIC TESTS; HEMORRHAGE; HUMANS; INFANT; PHYSICAL EXAMINATION; QUESTIONNAIRES; REFERRAL AND CONSULTATION;

EID: 84255161632     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1297166     Document Type: Article

References (62)

1. Werner E J., Broxson E H., Tucker E L., Giroux D S., Shults J, Abshire T C. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993 123 6 893-898 (Pubitemid 23353251)
2. Bowman M, Hopman W M., Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost 2010 8 1 213-216
3. Bowman M, Hopman W M., Rapson D, Lillicrap D, Silva M, James P. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population. Pediatr Blood Cancer 2010 55 1 171-173
4. Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders. Haemophilia 2008 14 Suppl 3 202-210 (Pubitemid 351722403)
5. Salles I I., Feys H B., Iserbyt B F., De Meyer S F., Vanhoorelbeke K, Deckmyn H. Inherited traits affecting platelet function. Blood Rev 2008 22 3 155-172
6. Nurden P, Nurden A T. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008 99 2 253-263 (Pubitemid 351230953)
7. Hayward C P., Rao A K., Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006 12 Suppl 3 128-136
8. Blanchette V S., Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Pediatr Clin North Am 2008 55 2 393-420, ix (Pubitemid 351442783)
9. Cines D B., Bussel J B., McMillan R B., Zehnder J L. Congenital and acquired thrombocytopenia. Hematology (Am Soc Hematol Educ Program) 2004 390-406
10. Anwar R, Minford A, Gallivan L, Trinh C H., Markham A F. Delayed umbilical bleedinga presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 2002 109 2 E32
11. Carcao M D., Blanchette V S. Work-up of a bleeding child. In: Lee C Berntorp E Hoots K eds. Textbook of Hemophilia. 2nd ed. West, Sussex, UK Blackwell 2010 118-126
12. Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost 2009 7 Suppl 1 84-87
13. Simon D, Kunicki T, Nugent D. Platelet function defects. Haemophilia 2008 14 6 1240-1249
14. Nosek-Cenkowska B, Cheang M S., Pizzi N J., Israels E D., Gerrard J M. Bleeding/bruising symptomatology in children with and without bleeding disorders. Thromb Haemost 1991 65 3 237-241
15. Lillicrap D, Nair S C., Srivastava A, Rodeghiero F, Pabinger I, Federici A B. Laboratory issues in bleeding disorders. Haemophilia 2006 12 Suppl 3 68-75
16. Rodeghiero F, Kadir R A., Tosetto A, James P D. Relevance of quantitative assessment of bleeding in haemorrhagic disorders. Haemophilia 2008 14 Suppl 3 68-75 (Pubitemid 351722386)
17. Rodeghiero F, Castaman G, Tosetto A et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005 3 12 2619-2626 (Pubitemid 41819788)
18. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006 4 4 766-773
19. Bowman M, Riddel J, Rand M L., Tosetto A, Silva M, James P D. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009 7 8 1418-1421
20. Biss T T., Blanchette V S., Clark D S. et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010 8 5 950-956
21. Biss T T., Blanchette V S., Clark D S., Wakefield C D., James P D., Rand M L. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost 2010 8 6 1416-1419
22. Tosetto A, Castaman G, Rodeghiero F. Bleeding scores in inherited bleeding disorders: clinical or research tools? Haemophilia 2008 14 3 415-422 (Pubitemid 351638726)
23. Clinical and Laboratory Standards Institute. Platelet Function Testing By Aggregometry; Approved Guideline. 2008 Vol. 28, No. 31
24. Cariappa R, Wilhite T R., Parvin C A., Luchtman-Jones L. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol 2003 25 6 474-479 (Pubitemid 36682753)
25. Schlammadinger A, Kerenyi A, Muszbek L, Boda Z. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease. Thromb Haemost 2000 84 1 88-92 (Pubitemid 30433674)
26. Posan E, McBane R D., Grill D E., Motsko C L., Nichols W L. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 2003 90 3 483-490 (Pubitemid 37138774)
27. Quiroga T, Goycoolea M, Muñoz B et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2004 2 6 892-898 (Pubitemid 40185736)
28. Kundu S K., Heilmann E J., Sio R, Garcia C, Davidson R M., Ostgaard R A. Description of an in vitro platelet function analyzerPFA-100. Semin Thromb Hemost 1995 21 Suppl 2 106-112
29. Favaloro E J., Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999 62 3 165-174 (Pubitemid 29521764)
30. Francis J, Francis D, Larson L, Helms E, Garcia M. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice? Platelets 1999 10 2-3 132-136 (Pubitemid 29182281)
31. Carcao M D., Blanchette V S., Dean J A. et al. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998 101 1 70-73 (Pubitemid 28197777)
32. Karger R, Donner-Banzhoff N, Müller H H., Kretschmer V, Hunink M. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis. Platelets 2007 18 4 249-260 (Pubitemid 46854816)
33. Hayward C P., Harrison P, Cattaneo M, Ortel T L., Rao A K. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006 4 312-319
34. Kratzer M AA, Kretschmer V. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet functiona rebuttal. J Thromb Haemost 2006 4 1429-1431
35. Koscielny J, Kiesewetter H, von Tempelhoff G F. More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006 4 6 1426-1427, discussion 14281434
36. Varon D, Dardik R, Shenkman B et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997 85 4 283-294 (Pubitemid 27143804)
37. Revel-Vilk S, Varon D, Shai E et al. Evaluation of children with a suspected bleeding disorder applying the Impact-R [Cone And Plate(Let) Analyzer]. J Thromb Haemost 2009 7 1990-1996
38. Quiroga T, Goycoolea M, Giesen P L. et al. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages. Pathophysiol Haemost Thromb 2003 33 1 30-35 (Pubitemid 37449293)
39. Eugster M, Reinhart W H. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005 94 6 1213-1218 (Pubitemid 41819618)
40. Carcao M D., Blanchette V S., Stephens D et al. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). Br J Haematol 2002 117 4 961-964 (Pubitemid 34639263)
41. Tosetto A, Castaman G, Rodeghiero F. Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach. Blood 2008 111 8 3998-4003
42. Acharya S S., Coughlin A, Dimichele D M., North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004 2 2 248-256 (Pubitemid 40186038)
43. Bernardi F, Dolce A, Pinotti M et al, International Factor VII Deficiency Study Group. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost 2009 7 5 774-779
44. Plug I, Mauser-Bunschoten E P., Bröcker-Vriends A H. et al. Bleeding in carriers of hemophilia. Blood 2006 108 1 52-56 (Pubitemid 43990612)
45. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008 14 6 1190-1200
46. Spreafico M, Peyvandi F. Combined factor V and factor VIII deficiency. Semin Thromb Hemost 2009 35 4 390-399
47. Nichols W L., Hultin M B., James A H. et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 14 2 171-232 (Pubitemid 351343618)
48. Nurden A T., Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007 21 1 21-36 (Pubitemid 46097190)
49. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009 35 2 189-203
50. Rao A K. Inherited defects in platelet signaling mechanisms. J Thromb Haemost 2003 1 4 671-681
51. Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009 113 25 6288-6295
52. Albert M H., Bittner T C., Nonoyama S et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood 2010 115 16 3231-3238
53. Owen C. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML). Leuk Res 2010 34 2 141-142
54. Ballmaier M, Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol 2009 146 1 3-16
55. Geddis A E., Kaushansky K. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production. Curr Opin Pediatr 2004 16 1 15-22 (Pubitemid 38168156)
56. Toriello H V. Thrombocytopenia absent radius syndrome. In: Genereviews [Internet]. Seattle, WA University of Washington 2009
57. Pham A, Wang J. Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med 2007 131 12 1834-1836 (Pubitemid 350294586)
58. Pallotta R, Evangelista V, Margaglione M, Bucci I, Saponari A. Macrothrombocytopenia in velocardiofacial syndrome. J Thromb Haemost 2005 3 3 601-603
59. Favaloro E J. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin? Semin Thromb Hemost 2008 34 1 113-127
60. Behrens W E. Mediterranean macrothrombocytopenia. Blood 1975 46 2 199-208
61. Kacena M A., Kirk J, Chou S T., Weiss M J., Raskind W H. GATA1-related X-linked cytopenia. In: Pagon R A. Bird T D. Dolan C R. Stephens K eds. GeneReviews [Internet]. University of Washington, Seattle, 2006
62. Gunay-Aygun M, Zivony-Elboum Y, Gumruk F et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 2010 116 23 4990-5001